Regulations surrounding the use of plasma and plasma-derived therapies vary from country to country. While some countries have well-established regulatory frameworks in place, others may be in the process of developing or refining their regulations. These regulations are designed to ensure that plasma-derived therapies are safe, effective, and meet high standards of quality. In some cases, they may also be used to ensure that plasma donors are screened and tested for infectious diseases before their plasma is used to create therapies. Understanding the regulatory landscape is crucial for those involved in the development, manufacturing, and use of plasma-derived therapies.

Find more here.